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Original Report
Conventional tube testing was used for antibody screening and 
titration in D– pregnant women in our hospital until the recent 
introduction of the gel test. In this study we assessed the sensitivity 
of the gel test in our setup and tried to establish a correlation 
between these tests for determining antibody titer. We collected 
652 blood samples from 223 antenatal D– women during a span of 
1 year. The samples were tested separately by the conventional tube 
technique and the gel test for antibody detection and titration. The 
tube test detected 84 (12.8%) positive samples as compared with 
93 (14.2%) by gel test, indicating the latter to be more sensitive 
(p < 0.01). The gel test picked up weakly reactive anti-D that the 
tube test missed. We did not use any enhancing media such as 
LISS in titration studies performed by either method in an effort 
to establish a correlation. However, much higher titers (one- to 
fivefold) were obtained by the gel test with no clear correlation 
with the corresponding tube values. When comparing the titer 
values to the finding of hydrops on ultrasound and Liley’s chart 
OD reading on amniocentesis, a value of less than 128 (i.e., 64) 
by gel test corresponded to normal results. Through this study, 
we thus conclude that the gel test is more sensitive for antibody 
detection, although a linear correlation could not be established 
for titers. Clinical correlation may point toward a critical titer of 
64 for the gel test, but further studies need to be done to support 
this finding. Immunohematology 2010;26:174–77.
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Hemolytic disease of the fetus and newborn (HDFN) 
was first reported in 1609,1 although the discovery of the Rh 
system was made in 1939 and the implication of D antigen 
in its pathogenesis in 1940.2 However, to the present day, 
researchers and clinicians alike have worked to unravel its 
pathogenesis, effects, prevention, and treatment.
Anti-D is by far the most common cause of HDFN 
although its incidence has drastically fallen with antenatal 
D immunoglobulin use as prophylaxis. Other antibodies 
are also implicated, and their prevalence has been studied 
in the Western world but such data are lacking in the 
Indian population. The antibodies can be identified as 
well as semiquantitated from the mother’s serum. Titer 
determination of anti-D by tube test helps in the clinical 
decision to proceed with an invasive procedure such as 
amniocentesis.
The conventional tube test has stood the test of time 
in both antibody detection and titration. The gel test 
introduced by Lapierre et al.3 in 1990 has gained popularity 
as a result of its standardized performance, technical ease, 
stable end point, and versatility of methodology. There have 
been many studies to show its superiority versus the tube 
test for antibody detection. The blood transfusion services 
in our country are gradually introducing gel technology for 
grouping, compatibility testing, and alloantibody detection 
owing to the many advantages. However, in some situations 
such as HDFN not only the specificity of alloantibody but 
also its titer has a direct impact on the fetus. Therefore, 
we evaluated the gel test and the conventional tube test 
for antibody screening and titration to determine if there 
is any correlation between the results obtained by using 
both technologies and to find out whether critical levels 
of alloantibody could be determined. We further studied 
obstetric management such as ultrasonography and 
intrauterine transfusion. We tried to correlate the titers 
with these clinical interventions.
Material and Methods
The duration of study was from July 2005 to June 2006, 
during which a total of 652 clotted samples were collected 
from 223 antenatal D– women. The study was conducted 
after approval from the Institute Ethics Committee. A 
written informed consent was taken from the patients for 
the study.
Sample Collection
A 3-mL clotted sample was collected, which was then 
centrifuged and the serum separated. Serum was stored in 
a frozen state at –80°C in two aliquots each until further 
testing. The first sample was taken in the first trimester or at 
the time of the first visit. Subsequent samples were taken in 
every trimester and at 28 weeks before the administration 
of anti-D immunoglobulin. Immunized women were 
followed up every 3 to 4 weeks.
Antibody Detection
The serum was thawed to room temperature before 
being tested. Antibody detection was done in parallel by the 
conventional tube technique and the gel test. A commercially 
available three-cell screening panel (DiaScreen; DiaMed, 
Cressier sur Morat, Switzerland) was used. For tube testing, 
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a 3% suspension in normal saline was used, and for gel 
testing, a 0.8% suspension in LISS was used.
Tube IAT
One drop of RBC suspension was added to two drops of 
serum to be tested into labeled test tubes. The tubes were 
incubated in a water bath at 37°C for 60 minutes. After 
three washes with normal saline solution, polyspecific anti-
human globulin was added to the RBC button and the tube 
was centrifuged at 3000 x g for 15 seconds in an appropriate 
centrifuge. The tubes were examined for agglutination. 
The reactions were graded and recorded as per the AABB 
Technical Manual.4
Gel Test
We dispensed 50 µL of RBCs into labeled gel cards 
and added 25 µL of the serum to be tested. The cards were 
incubated for 15 minutes at 37°C in specially designed 
incubators. They were then centrifuged at 1050 rpm for 10 
minutes. The reactions were graded and recorded. Antibody 
identification was done using commercially available panels 
(DiaMed) according to the manufacturer’s instructions.
Antibody Titration
Titration was performed on those samples that were 
positive on antibody screening. Serial twofold dilutions 
were made in normal saline solution in clean test tubes. 
The dilutions were tested in parallel for both tests. In-house 
prepared R1R1 RBCs from a single donor were used for D 
antibodies, whereas RBCs with heterozygous expression 
were used for Lea and Leb antibodies. The RBCs were washed 
three times in normal saline solution and resuspended 
to a final concentration of 3% and 0.8% in normal saline 
solution for tube testing and gel testing, respectively. 
Critical titer was taken as 16 by the tube technique followed 
in our institute.
Tube Test
The method used was the same as that for antibody 
detection.
Gel Test
The RBCs used were suspended in normal saline solution 
to a final concentration of 0.8%, and the cards incubated at 
37°C for 60 minutes. The remainder of the procedure was 
the same as for antibody detection. Titers were taken as 
the highest dilution that gave 1+ agglutination. The gel test 
had been modified from the manufacturer’s guidelines for 
titration. LISS was not used in the process, and the time of 
incubation was increased from 15 minutes to 60 minutes. 
We tested several samples in parallel with the standard 
method and found that deviating from the original method 
did not miss any antibodies.
The women who were positive for alloantibodies were 
investigated with ultrasonography for features of hydrops. 
The findings were compared with the titer values obtained 
by both methods. All women with titer values of 16 or above 
by the conventional tube method were further evaluated by 
amniocentesis. The OD values were plotted on Liley’s chart5 
and compared with the titer results by both methods.
Statistical analysis was performed using SPSS software 
version 13.0 (SPSS, Inc., Chicago, IL).
Results
On antibody screening, the tube technique detected 84 
(12.8%) positive results, whereas the gel test detected 93 
(14.2%) positive results individually. On comparison, 83 of 
the 84 positive by tube were also positive by gel, whereas 1 of 
the 84 was missed by gel. On the other hand 10 samples that 
were positive by gel had been missed by the tube technique. 
On identification the sample missed by gel was anti-Lea in 
specificity, and all samples missed by tube were anti-D in 
specificity. Both the tests showed a positive correlation in 
antibody detection that was significant with a Spearman’s 
correlation of +0.842 (p < 0.01). However, the gel technique 
proved to be more sensitive than the tube technique (p < 
0.01). Table 1 shows the profile of antibodies detected.
Table 2 compares the titer values obtained by both 
methods for D antibodies. The Lewis antibody titer values 
are compared in Table 3. The titers on gel were generally 
higher than those obtained by the tube technique, and as 
the tube titers increased, the gel titers also increased. The 
titer increase with the gel test was higher when compared 
with the tube test. The values varied from onefold to fivefold 
(mean, 1.6-fold). The observed differences were onefold in 
21 sera, twofold in 32, threefold in 18, fourfold in 3, and 
fivefold in 1. 
Obstetric Studies
Ultrasonography
The titers were compared with the fetal findings on 
ultrasonography, i.e., normal vs. hydropic. All the women 
with alloantibodies were investigated. The mean titer value 
for those who had normal ultrasonographic findings was 
62.39 by tube technique with a standard deviation of 114.5 
and titers ranging from 1 to 512. By the gel technique, the 
Table 1. Comparison of antibodies detected by both methods
Sample tested Tube Gel
Total 652 652
Tests positive 84 93
Anti-D (all) 73 83
Anti–D (passive) 11 21
Anti-C* 2 2
Anti Lea 6 5
Anti Leb 5 5
*Anti-C was found in association with anti-D.
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mean value was 271.04 with a standard deviation of 460.27 
and a range of 2 to 2048. The mean titer value for those who 
had hydropic findings on ultrasound was 182.86 by tube 
technique with a standard deviation of 145.138 and titers 
ranging from 128 to 512. By the gel technique, the mean 
value was 841.04 with a standard deviation of 604.259 and 
a range of 256 to 2048.
When compared using nonparametric tests, the 
difference between the two groups was significant by the 
tube method (p = 0.02) and also by gel test (p = 0.03). 
Table 4 shows the median values for normal and hydropic 
findings using both techniques.
Amniocentesis
The titer values by both methods were compared with 
the need for amniocentesis, which was performed on all 
women with a tube titer greater than 16. The values for the 
corresponding zones on Liley’s chart were compared by 
both methods. The comparison is shown in Table 5.
Discussion
Rh antigens are by far the most common cause of 
alloimmunization in pregnant women. The D antigen is 
the most immunogenic; yet, alloimmunization caused by it 
has been virtually eliminated in the Western world. Use of 
antibody screening and titration studies aid the obstetrician 
in deciding among early preventive or treatment modalities 
to manage HDFN.
Risk of HDFN can be diagnosed early in pregnancy 
with noninvasive serologic methods such as the indirect 
antiglobulin test to detect the presence of irregular 
antibodies in the maternal serum. Usually the firstborn 
is the initiator of sensitization to antigens present on fetal 
RBCs. This occurs mostly at delivery. During subsequent 
pregnancy reexposure to the same antigen initiates a 
secondary immune response and with the potential for the 
pathogenesis of HDFN. Antibody that has been detected 
in maternal serum must be identified. The antibody can 
then be quantitated using laboratory methods such as 
titration studies. The titration studies are useful in guiding 
the timing of clinical intervention required in utero. The 
noninvasive serologic methods precede the more invasive 
methods such as amniocentesis, which is associated with 
fetal morbidity and mortality.




Neg 1 2 4 8 16 32 64 128 256 512 1024 2048
Neg — — 6 4 — — — — — — — — —
1 — 2 2 5 2 1 — — — — — — —
2 — — 3 3 3 — — — — — — — —
4 — — — — 2 2 2 — — — — — —
8 — — — — 2 2 — 1 1 — — — —
16 — — — — — — 1 2 1 — — — —
32 — — — — — — — 1 4 3 1 1 —
64 — — — — — — — — 1 3 2 — —
128 — — — — — — — — 1 7 4 3 —
256 — — — — — — — — — — 2 1 —
512 — — — — — — — — — — — — 2
Total samples—83
Table 3. Titer values for Lewis antibodies by both methods
Lewis 
antibody 




samples per titer 
value
Lea 1 Neg 1
2 2 5
Leb 4 4 4
8 4 1
Total 11
Table 4.  Median titer values by both methods for antenatal 
ultrasound (USG) showing normal vs. hydropic changes
Median titer Normal on USG Features of hydrops
Tube 32 128
Gel 32 256
Table 5.  Median titer values by both methods for different zones of 
amniocentesis
Zone as per Liley’s 
chart (n)
Tube titer range 
(median)
Gel titer range 
(median)
Low zone (4) 16–64 64–512
(32) (128)
Mid zone (6) 32–512 128–2048
(64) (256)
High zone (8) 128–512 256–2048
(128) (718)
n = Number of women falling in each group.
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The higher sensitivity and versatility of the gel test 
compared with the tube test have been reported in various 
studies.6,7 A recent study comparing the conventional tube 
test with the gel technique for crossmatch also showed the 
latter to be more sensitive.8 Other positive points of the gel 
test include smaller volume of sample required, elimination 
of washing steps, stable results, and easy readability. The 
tube test in our study missed 10 examples of anti-D that the 
gel test detected. However, the anti-D in these samples were 
all attributable to antenatal anti-D immunoprophylaxis and 
they became undetectable after 4 to 6 weeks. Thus, the tube 
test did not miss any of the significant antibodies. Data 
are also presented that indicate the propensity of the gel 
test to miss clinically insignificant antibodies like Lea.7 The 
gel test in our study missed one sample of anti-Lea. Nine 
samples of anti-Lea and anti-Leb were, however, detected by 
both methods. The titration of antibodies by both methods 
showed variable results. Similar data have been published 
by Novaretti et al.9 in which they tested gel and tube titers 
for anti-D. They found the titers to be threefold to eightfold 
higher. Our study showed the titers to be one- to fivefold 
higher. The gel titers tended to be higher when compared 
with the tube titers. However, no correlation between the 
two methods could be found.
The recommended titration study by Judd10 is a saline 
antiglobulin procedure with 60-minute incubation at 37°C. 
In our study, we did not use LISS for gel titration, which 
is a known enhancing medium, in an attempt to establish 
a correlation, if any exists, between the conventional tube 
technique and the gel technique. Judd also stated that 
until substantial data are available that show correlation 
between gel microcolumn assay and saline tube antiglobulin 
titers IgG gel column technology should not be used for 
prenatal antibody titration. The critical tube titers of 16 
corresponded to gel titers ranging from 32 to 128. Hence, 
it is difficult to arrive at a definitive conclusion of critical 
gel titers when a direct correlation is attempted. When the 
titers were compared with ultrasonography for hydrops 
and amniocentesis OD values as per Liley’s chart, a gel 
value of less than 128 (i.e., 64) corresponded with normal 
ultrasonography and low zone OD values. However, this 
value should be interpreted with caution until more studies 
support it.
Based on the above observations, we conclude that 
the gel test is a better method than the conventional tube 
test for antibody detection because of its higher sensitivity 
and technical safety. Titration by gel, however, should 
not be considered for antenatal HDFN management as 
gel titers do not show linear correlation with tube titers, 
which predict fetal outcome in RhD sensitized women. 
Developing countries work under resource constraints, 
and such studies would optimize cost-effective use of this 
technology.
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